Skip to content
Tenfell
Awarded contract
Published 23 Aug 2024

NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024

NHS England · London

Key facts

Awarded
24 Jul 2024
Procedure
Open procedure (framework)
Buyer type
Central government

Awarded to 9 suppliers

SupplierValue
Bayer plc—
Teva UK Ltd—
Roche Products Ltd—
Thornton & Ross Ltd—
Abbvie Ltd—
Biogen Idec Ltd.—
Novartis Pharmaceuticals UK Ltd—
Alimera Sciences—
Orion Pharma (UK) Ltd—

Description

Project title: NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 Offer reference number CM/PHS/24/5707 Period of framework: 1 August 2024 to 31 July 2025. with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England The Procurement relates to the supply of medical retinal vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.